Researchers have found Brukinsa to be a potentially safer alternative for patients with chronic lymphocytic leukemia.
For some patients with bladder cancer, neoadjuvant chemotherapy plus bladder-saving concurrent chemoradiation therapy was ...
If the FDA follows an advisory committee’s vote, it can potentially be a transformative step in the delivery of mental health ...
Fresh flowers were indeed against ward policy. Theoretically, flowers could introduce fungal spores that could float through the air and lodge into the vulnerable lungs of our neutropenic patients.
FDA convened a joint meeting of its Drug Safety and Risk Management Advisory Committee and the Psychopharmacologic Drugs ...
14h
HealthDay on MSNAcalabrutinib-Venetoclax Prolongs Survival in Previously Untreated LeukemiaFor patients with previously untreated chronic lymphocytic leukemia (CLL), fixed-duration acalabrutinib-venetoclax with or without obinutuzumab significantly prolongs progression-free survival ...
During a Case-Based Roundtable® event, Natalie Galanina, MD, discussed data from the ZUMA-7 and TRANSFORM trials in the first ...
Radium-223 re-treatment is safe for metastatic castration-resistant prostate cancer, per findings from the 2025 ASCO GU ...
8d
Medpage Today on MSNMost Clozapine Prescribers Satisfied With REMS ProgramAmong 196 doctors who prescribed clozapine, 64% said the positive aspects of the REMS certification process outweighed the ...
Patient safety and well-being is behind Rosemere Cancer Foundation’s New Year re-reprint of chemotherapy alert cards.
Full enrollment in ongoing global, pivotal Phase 3 clinical trial in chronic neutropeniaon track for mid-2025Right-sizing commercial efforts to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results